
+

We are pleased to announce that Crown Laboratories, Inc. (“Crown”) and Revance Therapeutics, Inc. (“Revance”) have successfully completed the merger of the two companies.
Collectively, the Crown and Revance portfolios provide what we believe to be an industry-leading, comprehensive range of aesthetic solutions to practices and patients worldwide. The newly combined portfolio allows you, our practice partners, to achieve dynamic results and drive high patient satisfaction, growing your business through our differentiated brands and unwavering support.
All processes, support and representation for each company remain the same until further notice. We commit to clear communication and providing support throughout this process and will share more details as we have more information to share.
To learn more, please read the press release or reach out to your Crown Aesthetics representative.